TXG 10x Genomics Inc Sotuvning yalpi rentabelligi

10x (TXG) korporativ emblemasi va logotipi

10x Genomics, Inc. (TXG) qimmatbaho reagentlar sotuvidan olinadigan foydaga e'tibor qaratgan holda o'z biznes modelini optimallashtirmoqda. Kompaniya aniq to'qima xaritalarini yaratish uchun fazoviy biologiya sohasida yetakchilikka intilmoqda. Valdaromd ko'rsatkichi ushbu strategiyaning samaradorligini namoyish etadi, bunda 72.50 ushbu metrikaning darajasini ko'rsatadi. Ushbu rivojlanish laboratoriyadagi rutsin mehnatni bartaraf etuvchi avtomatlashtirilgan genom tahlili tizimlarining yaratilishiga olib keldi.

10x Genomics (TXG): Yalpi foyda bo'yicha rentabellik 04.07.2022dan 20.11.2026gacha

10x Genomics (TXG) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:TXG (10x Genomics)
10xgenomics.com yetakchi tovari

10x Genomics, Inc. (TXG) kompaniyasining qimmat uskunalar sotuvini reagentlarning takroriy sotuvi bilan birlashtirgan "razor-and-blade" modeli bevosita yuqori ishlab chiqarish samaradorligini belgilaydi. Valo martaba (gross margin) tushumning sotilgan tovarlar tannarxidan tashqari qismini o'lchaydi va biznesning operatsion xarajatlargacha foyda keltirish qobiliyatini aks ettiradi, bu esa investorga yalpi rentabellik grafigi orqali kompaniyaning narxlarni belgilash kuchini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|Yalpi foyda bo'yicha rentabellik NTLA|Stoke Therapeutics Inc (STOK) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja BLFS|Yalpi rentabellik WVE (Wave Life Sciences Corp)|Yalpi rentabellik Maze Therapeutics MAZE|Yalpi foyda normasi SION|PRME - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Taysha TSHA|QURE: Yalpi marja|Yalpi foyda bo'yicha rentabellik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik